Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Eye Manifestations in Finland
Total 0 results
Nothing found
Sponsors and Collaborators
Université de Genève (UNIGE)
Smart Meter Corporation
Impulse Dynamics, Inc.
Vivid Pharma Inc.
BioNova Pharmaceuticals (Shanghai) LTD.
Zhongda Hospital, Medical School, Southeast University
Defence Services Medical Academy (DSMA), Myanmar
The Affiliated Hospital of Xuzhou Medical University
Cogniciti
Pia Jaeger, MD, PhD
Huisartspraktijk Handellaan
NERv Technology Inc
Salena Killion
HBSA
UNITI Consortium
Shanghai GeneChem Co., Ltd.
Nutrabolt
Ministry of Public Health, Cameroon
Hungarian Dental Association
Health Information Technology Solutions (HITS) LLC
View Full List
Medical Conditions
VEXAS Syndrome
Infection, Bacterial
Endoleaks
Alzheimer Disease Focal
Cardiovascular Primary Prevention
Pain, Breakthrough
Advanced Bladder Carcinoma
Radiofrequency Ablation Treatment
Failed Induction
Immediate Implant Placement
Vertebral Compression Fractures in Osteoporotic Patients
PET-CT Specimen Imager
Biomarkers, Pharmacological
Research Mentoring Skills
PPA Syndrome
Eye Disease, Hereditary
Cerebral Arterial Disease
SMA - Spinal Muscular Atrophy
Old Age (Focus; Not a Recognized Condition)
Premature Rupture of Membranes Prolonged
View Full List
Drug Interventions
HPN328
20 mg/kg IV FL-301
TQB2450
INT-747
Lacosamide
Rosuvastatin
Microneedling with topical glycolic acid 35%.
OXP005
18F-FDG
Acetylsalicylic acid
Oxymorphone hydrochloride (HCl)
Cefadroxil until drain removal
0.75% Ropivacaine
Olopatadine hydrochloride 0.2%
CNTO 6785 50 mg
5 FU continuous
80% oxygen
Phase B: Triplixam / Elestar HCT
Durvalumab + chemotherapy treatment
CJ-12420 200mg + Clarithromycin 500mg
View Full List
CROs by country
Contract Research Organizations in Belgium
Contract Research Organizations in China
Contract Research Organizations in El Salvador
Contract Research Organizations in France
Contract Research Organizations in Ireland
Contract Research Organizations in Kazakhstan
Contract Research Organizations in Macedonia
Contract Research Organizations in Netherlands
Contract Research Organizations in Oman
Contract Research Organizations in Russia
Contract Research Organizations in Singapore
Contract Research Organizations in Sri Lanka
Contract Research Organizations in Uzbekistan
CRO list by country
CROs in Algeria
Nagy Research
Clinica Group
Axelys Sante
SGS
All CROs in Algeria
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe